Topical rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: Follow up of a pilot study and promising future directions
Author:
Affiliation:
1. Department of Paediatric Dermatology; Princess Margaret Hospital for Children; Subiaco Western Australia Australia
2. Pharmacy Department; Princess Margaret Hospital for Children; Subiaco Western Australia Australia
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajd.12125/fullpdf
Reference14 articles.
1. Tuberous sclerosis;Curatolo;Lancet,2008
2. Topical 0.1% rapamycin for angiofibromas in paediatric patients with tuberous sclerosis: a pilot study of four patients;Foster;Australas. J. Dermatol.,2012
3. Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis;Haemel;Arch. Dermatol.,2010
4. Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol;DeKlotz;Arch. Dermatol.,2011
5. Treatment of facial angiofibromas with topical application of oral rapamycin solution (1 mg mL)) in two patients with tuberous sclerosis;Mutizwa;Br. J. Dermatol.,2011
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and Safety of Topical Sirolimus for the Treatment of Angiofibromas in Tuberous Sclerosis: a Systematic Review and Meta-analysis;Current Pharmacology Reports;2023-12-13
2. A novel rapamycin cream formulation improves facial angiofibromas associated with tuberous sclerosis complex: a double-blind randomized placebo-controlled trial;British Journal of Dermatology;2023-07-18
3. Tuberous Sclerosis Complex;The Keio Journal of Medicine;2023
4. Púrpura retiforme secundaria a rickettsia conorii;Galicia Clínica;2023
5. Analysis of current data on the use of topical mTOR inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex—An update;Journal of the European Academy of Dermatology and Venereology;2022-11-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3